Cancer Immunotherapy a late sucess story

Forged out of the knowledge from decades of cancer and immunology research, Immunotherapy is emerging as an effective therapy against cancer. Saman Maleki profiles the recent development of a new immunotherapy drug, Ipilimumab, which disables one of cancer’s defences against immune cell attack.

Cancer Immunotherapy a late sucess story. Published in The Londoner (August 21th, page 10).

Saman Maleki holds a PhD in Cancer Immunology from Western University.

Part of the monthly series “Promise and Progress in Research” co-ordinated by the Canadian Cancer Society Volunteer Research Information Outreach Team (RIOT), London and published in The Londoner.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s